Germany | Bayern

Zurück zur Suche

Internationale Partnersuche

Forschung & Entwicklung Anfrage

Biotech, diagnostic equipment manufacturers sought for Eurostars project to develop high volume, rapid, bovine tuberculosis tests.

Country of Origin: United Kingdom
Reference Number: RDUK20180207001
Publication Date: 7 February 2018

Summary

A UK biotech SME has developed a unique, rapid diagnostic test for live bacteria that cause bovine tuberculosis (bTB) not just in cattle but many other animal species. It should save significant costs and unnecessary culling in global meat and dairy industries. Just launching the product in single unit test form the company seeks biotech manufacturing partners in the Netherlands or Denmark to join a development project to scale-up the test in a Eurostars funded development project.

Description

The incidence of bovine tuberculosis (bTB) represents a real cost to meat and dairy industries across the world. Although it appears to have been eradicated in most of Europe, pockets of the disease still stubbornly persist in wildlife in countries such as the UK, USA and Canada posing a risk to cattle, sheep and goat herds requiring stringent control measures in all countries. 

Diagnostic testing for the disease is a critical factor in these measures but current skin tests based on an animal’s immune response take 3 days to produce results and, more worryingly, such tests are known to miss about 20% of the animals. Other, more accurate tests require many days, up to 3 months, to produce meaningful results meaning that major costs are incurred as the disease spreads through whole herds before it is detected.

A UK biotech SME has successfully developed a unique test directly detecting live bacteria in blood or milk. It is fast and highly sensitive with the potential to produce results within 6 hours.

The company is about to launch diagnostic products based on this technology which it will manufacture as single test kits. Significant international interest from governments, regulatory authorities and primary meat and dairy producers is already being shown which indicates a requirement to scale this test to cope with high volume demands. The UK company therefore wishes to work with a biotech diagnostic equipment manufacturer to develop a high volume test system utilising this technology.

It is intended to make an application for Eurostars support by the closing date of 1st March 2018, so the UK company seeks a biotech diagnostics manufacturing partner in either the Netherlands or Denmark. The partner should be able to introduce ideas, processes and automation technologies that would enable testing to be scaled-up from the existing single tube test to the equivalent of a 96 plate array. Expressions of interest are required by Friday 16th February 2018.
Image

Image

Advantages and Innovations

•	Fast response with results available in 6 – 8 hours (i.e. same day) compared to between 1 – 3 months for the current “gold standard” tests. This ensures early detection of infection thus enabling far more effective treatment and control.

• Sensitivity and specificity better than current “gold standard” tests.

• Simple to operate and cost effective compared to current “gold standard” tests, offering attractive sales margins.

• Technology has been developed from university research and has been scientifically peer reviewed ensuring its validity.

• The core technology is patent protected ensuring any collaboration partner can enjoy competitive advantage in their markets.

Expertise sought

From their experience and expertise, the partner should be able to introduce ideas, processes and automation technologies that would enable the bio-technology to be scaled-up from the existing single tube test to the equivalent of a 96 plate array test.

Stage Of Development

Proposal under development

Stage Of Development Comment

The basic product in single test kit form has been fully developed and proven to provide the accuracy and rapid response capability required. It is now ready for market launch. However, the need to scale this test in order to handle the high volume demand early interest indicates, has not been addressed and the UK company needs the experience and expertise of a manufacturing partner to achieve this.

Requested partner

The partner needs to be a company engaged in the manufacture of medical or veterinary diagnostic equipment. They need to be located in either the Netherlands or Denmark and keen to participate in a Eurostars supported development project. From their experience and expertise, the partner should be able to introduce ideas, processes and automation technologies that would enable the bio-technology to be scaled-up from the existing single tube test to the equivalent of a 96 plate array test.

Dissemination Countries

Denmark, Netherlands

Cooperation offer ist closed for requests